18 participants
Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-13
- Start Date:
- 2026-05-30
- Completion:
- 2027-06-30
Conditions
- mRNA Vaccine
- Solid Tumor Cancer
- Peptides
- Cancer Metastatic
Interventions
- BIOLOGICAL
No Results Yet